PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding PDS Biotechnology Corp changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 32 | 46 | +14 |
| Shares | 3.15M | 6.06M | +2.91M (+92.6%) |
| Value | $14.3M | $74.4M | +$60.1M (+420.0%) |
New holders (26)
Institutions that held PDS Biotechnology Corp at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (12)
Institutions that held PDS Biotechnology Corp at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Ikarian Capital, LLC | 383,373 | $1.75M |
| Minot Wealth Management LLC | 45,439 | $207.0K |
| Marshall Wace, LLP | 44,232 | $201.0K |
| Boothbay Fund Management, LLC | 42,937 | $195.0K |
| Millennium Management LLC | 21,132 | $96.0K |
| Goldman Sachs Group Inc | 20,867 | $95.0K |
| Lincoln National Corp | 16,647 | $76.0K |
| Virtu Financial LLC | 10,602 | $48.0K |
| Cetera Investment Advisers | 10,500 | $48.0K |
| Royal Bank of Canada | 4,000 | $18.0K |
| Total Clarity Wealth Management, Inc. | 1,500 | $7.00K |
| Group One Trading, L.P. | 25 | $0 |